Resultados da busca - Michael F. Press
- Mostrando 1 - 20 resultados de 93
- Ir para a próxima página
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2), and Epidermal Growth Factor Receptor Expression and Benefit From Lapatinib in a Randomize... por Richard S. Finn, Michael F. Press, Judy Dering, Michael Arbushites, María Koehler, Cristina Oliva, Lisa S. Williams, Angelo Di Leo
Publicado em 2009Artigo -
8
-
9
-
10
-
11
Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academi... por Michael F. Press, Ivonne Villalobos, Angela Santiago, Roberta Guzman, Monica Cervantes, Armen Yuri Gasparyan, Anaamika Campeau, Yanling Ma, Denice Tsao‐Wei, Susan Groshen
Publicado em 2016Artigo -
12
Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells por Maria Corinna Palanca-Wessels, Garrett C. Booth, Anthony J. Convertine, Brittany B. Lundy, Geoffrey Y. Berguig, Michael F. Press, Patrick S. Stayton, Oliver W. Press
Publicado em 2016Artigo -
13
Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers por Wenhsiang Wen, Wangjuh Chen, Nick Xiao, Ryan Bender, Anatole Ghazalpour, Zheng Tan, Jeffrey Swensen, Sherri Z. Millis, Gargi D. Basu, Zoran Gatalica, Michael F. Press
Publicado em 2015Artigo -
14
-
15
Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting por Tove Olafsen, Guifu Tan, C W Cheung, Paul J. Yazaki, Jinha Park, John E. Shively, Lawrence E. Williams, Andrew Raubitschek, Michael F. Press, Anna M. Wu
Publicado em 2004Artigo -
16
Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger por Mia M. Gaudet, Michael F. Press, Robert W. Haile, Charles F. Lynch, Sally L. Glaser, Joellen M. Schildkraut, Marilie D. Gammon, W. Douglas Thompson, Jonine L. Bernstein
Publicado em 2011Artigo -
17
Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: Pooled results from three countries por Michael E. Jones, Flora E. van Leeuwen, Wilhelmina E. Hoogendoorn, Marian J.E. Mourits, Harry Hollema, Hester van Boven, Michael F. Press, Leslie Bernstein, Anthony J. Swerdlow
Publicado em 2012Artigo -
18
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer por Nuran Bektas, Erik Noetzel, Jürgen Veeck, Michael F. Press, Glen Kristiansen, Amjad Naami, Arndt Hartmann, Arno Dimmler, Matthias W. Beckmann, Ruth Knüchel, Peter A. Fasching, Edgar Dahl
Publicado em 2008Artigo -
19
Prognostic Value of Intrinsic Subtypes in Hormone Receptor–Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib por Aleix Prat, Maggie C.U. Cheang, Patricia Galván, Paolo Nucíforo, Laia Paré, Bárbara Adamo, Montserrat Muñoz, Margarida Viladot, Michael F. Press, Robert Gagnon, Catherine Ellis, Stephen Johnston
Publicado em 2016Artigo -
20
Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women por Veronica Wendy Setiawan, Li-Hao Chu, Esther M. John, Yuan Chun Ding, Sue A. Ingles, Leslie Bernstein, Michael F. Press, Giske Ursin, Christopher A. Haiman, Susan L. Neuhausen
Publicado em 2008Artigo
Ferramentas de busca:
Assuntos relacionados
Cancer
Medicine
Internal medicine
Breast cancer
Oncology
Biology
Gene
Genetics
Population
Gynecology
Pathology
Sociology
Trastuzumab
Confidence interval
Genotype
Environmental health
Single-nucleotide polymorphism
Cancer research
Demography
Genome-wide association study
Biochemistry
Metastatic breast cancer
Odds ratio
Estrogen receptor
Genetic association
Immunohistochemistry
Chemotherapy
Lapatinib
Locus (genetics)
Obstetrics